Zilretta
NDC 65250-003, triamcinolone acetonide extended-release injectable suspension, kit, from Pacira Pharmaceuticals, Inc..
- Product NDC
- 65250-003
- Status
- Listed
- Labeler
- Pacira Pharmaceuticals, Inc.
- Dosage form
- KIT
- Route
- INTRA-ARTICULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208845
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65250-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65250-003-01 | 65250000301 | 1 KIT in 1 CARTON (65250-003-01) * 1 INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE in 1 VIAL, SINGLE-DOSE (65250-001-01) * 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE (65250-002-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cd5c4673-21f2-4126-9556-da847b3a228bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65250-003
Use it
Look up 65250-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65250-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65250-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.